Marcelo Volpon Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcelo Volpon Santos has a total of 272 co-authors. Here are the top co-authors by number of shared publications:
- Hélio Rubens Machado
Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto
13 shared publications - Luciano Furlanetti
Clinica de Dor e Funcional, São Paulo, Brazil
10 shared publications - Ricardo Santos de Oliveira
Division of Neurosurgery, Department of Surgery and Anatomy, University Hospital, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
7 shared publications - Ricardo Santos de Oliveira
Instituto Fernandes Figueira
6 shared publications Hélio Rubens Machado
Department of Surgery and Anatomy , Ribeirao Preto Medical School , University of Sao Paulo (USP) , São Paulo , Brazil , usp.br
5 shared publicationsRicardo Santos de Oliveira
Department of Surgery and Anatomy, Division of Neurosurgery, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
5 shared publications
Latest Publications
Longitudinal Bayesian analysis of lobe‐specific cognitive outcomes after pediatric epilepsy surgery
Objective: To examine the impact of the operated brain region and clinical–surgical variables on intellectual performance in children and adolescents undergoing neurosurgery for pharmacoresistant epilepsy. Methods: Fifty‐one participants were classified according to surgical site: temporal lobe (TL; n = 23), frontal lobe (FL; n = 9), posterior cortex (PC; n = 9), and hemispherotomy (H; n = 10). Neuropsychological assessment was performed using age‐appropriate versions of the Wechsler Intelligence Scales (Wechsler Intelligence Scale for Children/Wechsler Adult Intelligence Scale [WISC/WAIS]). Bayesian linear mixed models compared intelligence quotients and scale indices across three time points: preoperative (T0), 6‐month postoperative (T1), and 24‐month postoperative (T2). For each outcome, two models were fitted: a simple model and a multiple model adjusted for seizure frequency and epilepsy duration. Estimates were derived from posterior distributions with 95% credibility intervals. Analyses were conducted in R using MCMC sampling, with convergence assessed by trace plots and the Gelman–Rubin diagnostic. A change of ≥10 points was considered a clinically relevant improvement, whereas a decrease of ≥5 points indicated a relevant decline in longitudinal within‐group comparisons. Results reflect group‐level trajectories rather than individual outcomes. Results: At T1, the H group showed declines in Full‐Scale Intelligence Quotient (FSIQ), Verbal Comprehension Index (VCI), Perceptual Organization Index (POI), Working Memory Index (WMI), and Processing Speed Index (PSI). At T2, the FSIQ, POI, and WMI returned to near baseline, whereas VCI and PSI remained reduced. The TL group showed declines in VCI, WMI, and PSI at T1, with a persistent reduction in VCI at T2. FL and PC groups maintained intelligence indices close to baseline at both postoperative assessments. Significance: Epilepsy surgery preserved intellectual functioning, particularly in FL and PC procedures. However, persistent VCI decline in H and TL groups suggests effects on verbal abilities associated with temporal lobe involvement. Sustained PSI reduction after hemispherotomy may indicate decreased cognitive efficiency and slower information processing.
Longitudinal Bayesian analysis of lobe‐specific cognitive outcomes after pediatric epilepsy surgery
Objective: To examine the impact of the operated brain region and clinical–surgical variables on intellectual performance in children and adolescents undergoing neurosurgery for pharmacoresistant epilepsy. Methods: Fifty‐one participants were classified according to surgical site: temporal lobe (TL; n = 23), frontal lobe (FL; n = 9), posterior cortex (PC; n = 9), and hemispherotomy (H; n = 10). Neuropsychological assessment was performed using age‐appropriate versions of the Wechsler Intelligence Scales (Wechsler Intelligence Scale for Children/Wechsler Adult Intelligence Scale [WISC/WAIS]). Bayesian linear mixed models compared intelligence quotients and scale indices across three time points: preoperative (T0), 6‐month postoperative (T1), and 24‐month postoperative (T2). For each outcome, two models were fitted: a simple model and a multiple model adjusted for seizure frequency and epilepsy duration. Estimates were derived from posterior distributions with 95% credibility intervals. Analyses were conducted in R using MCMC sampling, with convergence assessed by trace plots and the Gelman–Rubin diagnostic. A change of ≥10 points was considered a clinically relevant improvement, whereas a decrease of ≥5 points indicated a relevant decline in longitudinal within‐group comparisons. Results reflect group‐level trajectories rather than individual outcomes. Results: At T1, the H group showed declines in Full‐Scale Intelligence Quotient (FSIQ), Verbal Comprehension Index (VCI), Perceptual Organization Index (POI), Working Memory Index (WMI), and Processing Speed Index (PSI). At T2, the FSIQ, POI, and WMI returned to near baseline, whereas VCI and PSI remained reduced. The TL group showed declines in VCI, WMI, and PSI at T1, with a persistent reduction in VCI at T2. FL and PC groups maintained intelligence indices close to baseline at both postoperative assessments. Significance: Epilepsy surgery preserved intellectual functioning, particularly in FL and PC procedures. However, persistent VCI decline in H and TL groups suggests effects on verbal abilities associated with temporal lobe involvement. Sustained PSI reduction after hemispherotomy may indicate decreased cognitive efficiency and slower information processing.
- Open Access
- 4 July 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1)
Challenging anatomical paradigms: unexpected supratentorial localization of posterior fossa B ependymomas identified by DNA methylation
Molecular subgroups of ependymomas are strongly associated with their primary anatomical compartments, namely the supratentorial region, posterior fossa and spine locations. Although it is generally accepted that posterior fossa ependymomas may arise from radial glia-like progenitor cells, the precise cellular origin of the distinct posterior fossa molecular subgroups remains to be determined. Given that DNA methylation profile strongly recapitulates developmental lineage and the cell of origin, the characterization of unexpectedly located molecular subgroups of ependymomas may provide insights into their cells of origin and potential migratory dynamics during embryogenesis and brain development. Herein, we describe two male school-aged pediatric patients with supratentorial tumors located in the third ventricle/pineal region that were classified as posterior fossa group B ependymomas based on DNA methylation profiling. To our knowledge, this represents the first reports of posterior fossa group B ependymomas identified outside the posterior fossa compartment.
- 4 July 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1)
Open AccessChallenging anatomical paradigms: unexpected supratentorial localization of posterior fossa B ependymomas identified by DNA methylation
Molecular subgroups of ependymomas are strongly associated with their primary anatomical compartments, namely the supratentorial region, posterior fossa and spine locations. Although it is generally accepted that posterior fossa ependymomas may arise from radial glia-like progenitor cells, the precise cellular origin of the distinct posterior fossa molecular subgroups remains to be determined. Given that DNA methylation profile strongly recapitulates developmental lineage and the cell of origin, the characterization of unexpectedly located molecular subgroups of ependymomas may provide insights into their cells of origin and potential migratory dynamics during embryogenesis and brain development. Herein, we describe two male school-aged pediatric patients with supratentorial tumors located in the third ventricle/pineal region that were classified as posterior fossa group B ependymomas based on DNA methylation profiling. To our knowledge, this represents the first reports of posterior fossa group B ependymomas identified outside the posterior fossa compartment.
- Open Access
- 19 January 2026
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 8 (1) , e3522026
When Conservative Management Fails: Pediatric Type III Odontoid Fracture With Delayed Instability
Introduction/Background: Pediatric cervical spine trauma is rare, with most injuries involving the upper cervical region. Type III odontoid fractures are commonly managed with external immobilization when atlantoaxial stability is preserved; however, radiographic progression and occult spinal cord compromise may still occur. Case presentation: A 7-year-old boy sustained high-energy cervical trauma after a fall from a three-story building. He reported mild, transient neck pain and had no neurological deficits. Cervical CT demonstrated a type III odontoid fracture extending to the right superior articular facet, associated with a single-line fracture of the left anterior arch of C1. Initial deformity was minimal (1 mm anterior translation and 6° anterior angulation), and he was treated with a rigid cervical collar. The patient was lost to follow-up and returned 3 months after injury; repeat CT showed marked deformity progression (42.5° anterior angulation and 4 mm translation). MRI revealed anterior spinal cord compression with intramedullary T2/STIR hyperintensity consistent with early radiological myelopathy, despite an unchanged and normal neurological examination. Given progressive instability and occult cord compromise, posterior C1–C2 stabilization with C1 decompression was performed under intraoperative neurophysiological monitoring. Postoperative recovery was uneventful. At 13 months, he remained neurologically intact, with solid fusion on CT and improvement of the intramedullary signal abnormality on MRI. Conclusions: Pediatric type III odontoid fractures may worsen during conservative management, and clinically silent cord compression with MRI evidence of myelopathy can occur. Timely, structured follow-up imaging is essential, and prompt stabilization should be considered when progression, instability, and/or cord compression is identified.
- 19 January 2026
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 8 (1) , e3522026
Open AccessWhen Conservative Management Fails: Pediatric Type III Odontoid Fracture With Delayed Instability
Introduction/Background: Pediatric cervical spine trauma is rare, with most injuries involving the upper cervical region. Type III odontoid fractures are commonly managed with external immobilization when atlantoaxial stability is preserved; however, radiographic progression and occult spinal cord compromise may still occur. Case presentation: A 7-year-old boy sustained high-energy cervical trauma after a fall from a three-story building. He reported mild, transient neck pain and had no neurological deficits. Cervical CT demonstrated a type III odontoid fracture extending to the right superior articular facet, associated with a single-line fracture of the left anterior arch of C1. Initial deformity was minimal (1 mm anterior translation and 6° anterior angulation), and he was treated with a rigid cervical collar. The patient was lost to follow-up and returned 3 months after injury; repeat CT showed marked deformity progression (42.5° anterior angulation and 4 mm translation). MRI revealed anterior spinal cord compression with intramedullary T2/STIR hyperintensity consistent with early radiological myelopathy, despite an unchanged and normal neurological examination. Given progressive instability and occult cord compromise, posterior C1–C2 stabilization with C1 decompression was performed under intraoperative neurophysiological monitoring. Postoperative recovery was uneventful. At 13 months, he remained neurologically intact, with solid fusion on CT and improvement of the intramedullary signal abnormality on MRI. Conclusions: Pediatric type III odontoid fractures may worsen during conservative management, and clinically silent cord compression with MRI evidence of myelopathy can occur. Timely, structured follow-up imaging is essential, and prompt stabilization should be considered when progression, instability, and/or cord compression is identified.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1) , 2442546
Molecular Characterization of Cerebellar Dysplastic Gangliocytoma With Clinical and Radiological Correlations
The purpose of this report is to describe the clinical, molecular, and imaging findings of the dysplastic gangliocytoma of the cerebellum (also called Lhermitte–Duclos disease), a rare pathological entity, with an emphasis on the genotype–phenotype correlation to further clarify its etiology and long‐term effects. The case reported herein refers to an 11‐year‐old boy with pharmaco‐resistant epilepsy, which eventually was associated with headaches, vomiting, and papilledema as the disease progressed. His magnetic resonance imaging (MRI) scans were compatible with a left cerebellar dysplasia. He underwent surgical treatment (excision of dysplastic cerebellar tissue) and improved significantly, remaining seizure‐free over a 3‐year follow‐up. Histopathological analysis revealed an increase in myelinization of axons in the molecular layer, the absence of Purkinje cells, hypertrophy in the granular cell layer, and atrophy of the white matter of the cerebellum. Furthermore, we performed whole‐exome sequencing (WES) of the patient’s samples to look for abnormal genetic variants. However, even though overactivation of the mechanistic target of rapamycin pathway has been found to play an essential role in the pathogenesis of cerebellar dysplasia, we were unable to identify pathogenic germline variants that could be associated with the observed phenotype. In conclusion, cerebellar dysplasia of the cerebellum is a complex disease with progressive clinical features, including refractory seizures, that responds well to surgical treatment. Further molecular studies are warranted to elucidate the pathogenesis of this rare pathology.
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1) , 2442546
Open AccessMolecular Characterization of Cerebellar Dysplastic Gangliocytoma With Clinical and Radiological Correlations
The purpose of this report is to describe the clinical, molecular, and imaging findings of the dysplastic gangliocytoma of the cerebellum (also called Lhermitte–Duclos disease), a rare pathological entity, with an emphasis on the genotype–phenotype correlation to further clarify its etiology and long‐term effects. The case reported herein refers to an 11‐year‐old boy with pharmaco‐resistant epilepsy, which eventually was associated with headaches, vomiting, and papilledema as the disease progressed. His magnetic resonance imaging (MRI) scans were compatible with a left cerebellar dysplasia. He underwent surgical treatment (excision of dysplastic cerebellar tissue) and improved significantly, remaining seizure‐free over a 3‐year follow‐up. Histopathological analysis revealed an increase in myelinization of axons in the molecular layer, the absence of Purkinje cells, hypertrophy in the granular cell layer, and atrophy of the white matter of the cerebellum. Furthermore, we performed whole‐exome sequencing (WES) of the patient’s samples to look for abnormal genetic variants. However, even though overactivation of the mechanistic target of rapamycin pathway has been found to play an essential role in the pathogenesis of cerebellar dysplasia, we were unable to identify pathogenic germline variants that could be associated with the observed phenotype. In conclusion, cerebellar dysplasia of the cerebellum is a complex disease with progressive clinical features, including refractory seizures, that responds well to surgical treatment. Further molecular studies are warranted to elucidate the pathogenesis of this rare pathology.
- Open Access
Somatic Mosaicism Patterns Define Clinical-Surgical Subtypes of Focal Cortical Dysplasia Through Cell-Type-Specific Expression
Focal Cortical Dysplasia Type II (FCDII) is a subtype of cortical malfunction and is the primary cause of drug-resistant epilepsy in children. Although somatic mosaicism and clonal expansion of brain cells have been identified as crucial factors in FCD cases, the overall genetic landscape and clinical implications of FCDII remain largely unclear due to a significant gap in translating genetic data to inform surgical approaches and prognostic evaluations of individual cases. We carried out deep exome sequencing and deep amplicon validation of surgical biopsies and matched blood samples from 14 FCDII patients with confirmed neuropathology. We further performed multiscale pathogenic validations and took advantage of existing single-nucleus RNA sequencing and spatial maps from developing human cortices to explore the functionality of potential pathogenic somatic variants. We identified novel somatic variants in several functional categories, like neurotransmission ( TAAR2, GRM6, ZACN ), structural regulation ( TUBB2A, PLEC, COL18A1 ), cellular maintenance ( IDO2, PARP4, P2RX5 ), and RNA processing ( RBMX ), mapping the expression of these genes back to the developing human brain demonstrated significant enrichment in neuronal cell types, especially excitatory neurons, further confirming their contributions in early brain development and phenotypic functions in dysmorphic neurons. Combining these genetic findings with clinical phenotypes, we found brain-specific mosaic variants with very high mosaic fractions (fraction of mosaic cells, MF, up to 99.5% on P2RX5 ) associated with different clinical phenotypes. FCDIIB, a more severe subtype that contains balloon cells, had higher MFs (>40%) for variants within resectable cortical layers (excitatory neurons in Layers 5 and 6). This allows potentially targeted resection and achieves better clinical outcome (87.5 % with Engel score I). FCDIIA subtype, on the other hand, displayed lower MFs ( 40% predicting viable focal resection and MF < 5% indicating network dysfunction that necessitates broad-spectrum resection. Combining genetic mapping with cellular localization thus offers a coherent solution to precision surgery in FCDII, translating molecular diagnosis to clinical practice.
Open AccessSomatic Mosaicism Patterns Define Clinical-Surgical Subtypes of Focal Cortical Dysplasia Through Cell-Type-Specific Expression
Focal Cortical Dysplasia Type II (FCDII) is a subtype of cortical malfunction and is the primary cause of drug-resistant epilepsy in children. Although somatic mosaicism and clonal expansion of brain cells have been identified as crucial factors in FCD cases, the overall genetic landscape and clinical implications of FCDII remain largely unclear due to a significant gap in translating genetic data to inform surgical approaches and prognostic evaluations of individual cases. We carried out deep exome sequencing and deep amplicon validation of surgical biopsies and matched blood samples from 14 FCDII patients with confirmed neuropathology. We further performed multiscale pathogenic validations and took advantage of existing single-nucleus RNA sequencing and spatial maps from developing human cortices to explore the functionality of potential pathogenic somatic variants. We identified novel somatic variants in several functional categories, like neurotransmission ( TAAR2, GRM6, ZACN ), structural regulation ( TUBB2A, PLEC, COL18A1 ), cellular maintenance ( IDO2, PARP4, P2RX5 ), and RNA processing ( RBMX ), mapping the expression of these genes back to the developing human brain demonstrated significant enrichment in neuronal cell types, especially excitatory neurons, further confirming their contributions in early brain development and phenotypic functions in dysmorphic neurons. Combining these genetic findings with clinical phenotypes, we found brain-specific mosaic variants with very high mosaic fractions (fraction of mosaic cells, MF, up to 99.5% on P2RX5 ) associated with different clinical phenotypes. FCDIIB, a more severe subtype that contains balloon cells, had higher MFs (>40%) for variants within resectable cortical layers (excitatory neurons in Layers 5 and 6). This allows potentially targeted resection and achieves better clinical outcome (87.5 % with Engel score I). FCDIIA subtype, on the other hand, displayed lower MFs ( 40% predicting viable focal resection and MF < 5% indicating network dysfunction that necessitates broad-spectrum resection. Combining genetic mapping with cellular localization thus offers a coherent solution to precision surgery in FCDII, translating molecular diagnosis to clinical practice.
- Open Access
Identification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions
Focal cortical dysplasia type III (FCDIII) is a rare and complex condition associated with drug-resistant epilepsy and often characterized by cortical lamination abnormalities, along with a variety of neoplasms and vascular abnormalities. Objectives: This study aimed to elucidate the genetic architecture underlying FCDIII through the use of whole-exome sequencing (WES) of brain and peripheral blood samples from 19 patients who had been diagnosed with FCDIII. Methods: Variants were identified through a series of machine-learning-based detection and functional prediction methods and were not previously associated with FCDIII. Mosaic fraction scores of these variants validated the variants’ pathogenicity, and in silico and gene ontology enrichment analyses demonstrated that these variants had severe destabilizing effects on protein structure. Results: We reported ten novel pathogenic somatic missense and loss of function variants across eight genes, including CNTNAP2, ACY1, SERAC1, and BRAF. Genetic alterations were linked to clinical manifestations, such as encephalopathies and intellectual disabilities, thereby emphasizing their role as molecular drivers of FCDIII. Conclusions: We demonstrated that next-generation sequencing-based mosaic variant-calling pipelines are useful for the genetic diagnosis of FCDIII, opening up avenues for targeted therapies, yet further research is required to validate these findings and examine their therapeutic implications.
Open AccessIdentification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions
Focal cortical dysplasia type III (FCDIII) is a rare and complex condition associated with drug-resistant epilepsy and often characterized by cortical lamination abnormalities, along with a variety of neoplasms and vascular abnormalities. Objectives: This study aimed to elucidate the genetic architecture underlying FCDIII through the use of whole-exome sequencing (WES) of brain and peripheral blood samples from 19 patients who had been diagnosed with FCDIII. Methods: Variants were identified through a series of machine-learning-based detection and functional prediction methods and were not previously associated with FCDIII. Mosaic fraction scores of these variants validated the variants’ pathogenicity, and in silico and gene ontology enrichment analyses demonstrated that these variants had severe destabilizing effects on protein structure. Results: We reported ten novel pathogenic somatic missense and loss of function variants across eight genes, including CNTNAP2, ACY1, SERAC1, and BRAF. Genetic alterations were linked to clinical manifestations, such as encephalopathies and intellectual disabilities, thereby emphasizing their role as molecular drivers of FCDIII. Conclusions: We demonstrated that next-generation sequencing-based mosaic variant-calling pipelines are useful for the genetic diagnosis of FCDIII, opening up avenues for targeted therapies, yet further research is required to validate these findings and examine their therapeutic implications.
- 5 January 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (10) , e1867-e1880
Epigenetic Control of Adamantinomatous Craniopharyngiomas
Introduction Studies addressing the methylation pattern in adamantinomatous craniopharyngioma (ACP) are lacking. Objective To identify methylation signatures in ACPs regarding clinical presentation and outcome. Methods Clinical and pathology data were collected from 35 patients with ACP (54% male; 18.1 years [2-68]). CTNNB1 mutations and methylation profile (MethylationEPIC/Array-Illumina) were analyzed in tumoral DNA. Unsupervised machine learning analysis of this comprehensive methylome sample was achieved using hierarchical clustering and multidimensional scaling. Statistical associations between clusters and clinical features were achieved using the Fisher test and global biological process interpretations were aided by Gene Ontology enrichment analyses. Results Two clusters were revealed consistently by all unsupervised methods (ACP-1: n = 18; ACP-2: n = 17) with strong bootstrap statistical support. ACP-2 was enriched by CTNNB1 mutations (100% vs 56%, P = .0006), hypomethylated in CpG island, non-CpG Island sites, and globally (P < .001), and associated with greater tumor size (24.1 vs 9.5 cm3, P = .04). Enrichment analysis highlighted pathways on signaling transduction, transmembrane receptor, development of anatomical structures, cell adhesion, cytoskeleton organization, and cytokine binding, and cell type-specific biological processes as regulation of oligodendrocytes, keratinocyte, and epithelial cells differentiation. Conclusion Two clusters of patients with ACP were consistently revealed by unsupervised machine learning methods, with one of them significantly hypomethylated, enriched by CTNNB1 mutated ACPs, and associated with increased tumor size. Enrichment analysis reinforced pathways involved in tumor proliferation and in cell-specific tumoral microenvironment.
- 5 January 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (10) , e1867-e1880
Epigenetic Control of Adamantinomatous Craniopharyngiomas
Introduction Studies addressing the methylation pattern in adamantinomatous craniopharyngioma (ACP) are lacking. Objective To identify methylation signatures in ACPs regarding clinical presentation and outcome. Methods Clinical and pathology data were collected from 35 patients with ACP (54% male; 18.1 years [2-68]). CTNNB1 mutations and methylation profile (MethylationEPIC/Array-Illumina) were analyzed in tumoral DNA. Unsupervised machine learning analysis of this comprehensive methylome sample was achieved using hierarchical clustering and multidimensional scaling. Statistical associations between clusters and clinical features were achieved using the Fisher test and global biological process interpretations were aided by Gene Ontology enrichment analyses. Results Two clusters were revealed consistently by all unsupervised methods (ACP-1: n = 18; ACP-2: n = 17) with strong bootstrap statistical support. ACP-2 was enriched by CTNNB1 mutations (100% vs 56%, P = .0006), hypomethylated in CpG island, non-CpG Island sites, and globally (P < .001), and associated with greater tumor size (24.1 vs 9.5 cm3, P = .04). Enrichment analysis highlighted pathways on signaling transduction, transmembrane receptor, development of anatomical structures, cell adhesion, cytoskeleton organization, and cytokine binding, and cell type-specific biological processes as regulation of oligodendrocytes, keratinocyte, and epithelial cells differentiation. Conclusion Two clusters of patients with ACP were consistently revealed by unsupervised machine learning methods, with one of them significantly hypomethylated, enriched by CTNNB1 mutated ACPs, and associated with increased tumor size. Enrichment analysis reinforced pathways involved in tumor proliferation and in cell-specific tumoral microenvironment.
- Open Access
- 15 October 2023
- Published by Wiley in X-Ray Spectrometry
- Vol. 52 (6) , 275
Issue Information
- 15 October 2023
- Published by Wiley in X-Ray Spectrometry
- Vol. 52 (6) , 275
Open AccessIssue Information
- 29 September 2023
- Published by Springer Nature
- Vol. 48, 327-354
Clinical and Surgical Approach for Cerebral Cortical Dysplasia
The present article describes pathophysiological and clinical aspects of congenital malformations of the cerebral tissue (cortex and white matter) that cause epilepsy and very frequently require surgical treatment. A particular emphasis is given to focal cortical dysplasias, the most common pathology among these epilepsy-related malformations. Specific radiological and surgical features are also highlighted, so a thorough overview of cortical dysplasias is provided. Keywords Cortical dysplasia Epilepsy Epilepsy surgery Malformations of cortical development Outcome
- 29 September 2023
- Published by Springer Nature
- Vol. 48, 327-354
Clinical and Surgical Approach for Cerebral Cortical Dysplasia
The present article describes pathophysiological and clinical aspects of congenital malformations of the cerebral tissue (cortex and white matter) that cause epilepsy and very frequently require surgical treatment. A particular emphasis is given to focal cortical dysplasias, the most common pathology among these epilepsy-related malformations. Specific radiological and surgical features are also highlighted, so a thorough overview of cortical dysplasias is provided. Keywords Cortical dysplasia Epilepsy Epilepsy surgery Malformations of cortical development Outcome
- 28 September 2023
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 133, 102344
Celecoxib attenuates neuroinflammation, reactive astrogliosis and promotes neuroprotection in young rats with experimental hydrocephalus
- 28 September 2023
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 133, 102344
Celecoxib attenuates neuroinflammation, reactive astrogliosis and promotes neuroprotection in young rats with experimental hydrocephalus